Rafferty Asset Management
ALBO

Rafferty Asset Management’s Albireo Pharma Inc ALBO Stock Holding History

Rafferty Asset Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-57,758
Closed -$1.15M – 1286
2022
Q2 		$1.15M Buy
57,758
+7,673
+15% +$202K 0.01% 601
2022
Q1 		$1.49M Sell
50,085
-14,203
-22% -$416K 0.01% 693
2021
Q4 		$1.5M Buy
64,288
+22,470
+54% +$597K 0.01% 759
2021
Q3 		$1.3M Buy
41,818
+11,565
+38% +$358K 0.01% 746
2021
Q2 		$1.06M Sell
30,253
-19,075
-39% -$620K 0.01% 866
2021
Q1 		$1.74M Buy
49,328
+41,775
+553% +$1.54M 0.01% 660
2020
Q4 		$283K Buy
+7,553
New +$275K ﹤0.01% 838

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Rafferty Asset Management's ALBO Position: Q3 2022 in Review

Rafferty Asset Management sold out of Albireo Pharma Inc (ALBO) in Q3 2022, closing a stake of 57,758 shares — an estimated $1.15M sold.

Rafferty Asset Management first reported a position in ALBO in Q4 2020 and held it in 7 quarters. The position peaked at $1.74M in Q1 2021. 108 funds tracked by Wall St. Rank hold ALBO as of Q3 2022.

  • Rafferty Asset Management reported no remaining Albireo Pharma Inc position as of Q3 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 57,758 Albireo Pharma Inc shares in Q3 2022, an estimated $1.15M.
  • Rafferty Asset Management first reported a position in Albireo Pharma Inc in Q4 2020 and held it in 7 quarters.
  • Rafferty Asset Management's Albireo Pharma Inc position peaked at $1.74M in Q1 2021.
  • 108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2022.

Based on Rafferty Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.